SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and care coordination, and TeleSpecialists LLC, a physician-owned management service organization committed to ...
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how the Viz HCM module enables ...
Viz.ai Wins Gold Edison Award™ for Advancing AI-Driven Clinical Workflows to Improve Hemorrhage Care
Fourth consecutive Edison Award underscores Viz.ai’s role as the infrastructure layer enabling AI-driven decision-making at the point of care SAN FRANCISCO, April 17, 2026--(BUSINESS WIRE)--Viz.ai, ...
The U.S. Food and Drug Administration's approval of Viz.ai's hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software. Viz.ai, a disease ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
New capability within Viz.ai One® Platform enables health systems to build and deploy customizable care pathways at scale—expanding how clinical guidelines are applied across every patient, every time ...
The startup has 12 FDA-approved algorithms to flag problems, agreements with more than 1,500 U.S. hospitals, and big plans to work with drug companies to reduce roadblocks in healthcare. On October 26 ...
Artificial intelligence disease detection and care coordination platform Viz.ai has launched the first agentic platform for health systems to build and deploy their own customizable care pathways. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results